Editors:
- Includes supplementary material: sn.pub/extras
Part of the book series: Cancer Drug Discovery and Development (CDD&D)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (10 chapters)
-
Front Matter
-
Back Matter
About this book
Comprehensive and state-of-the-art, Matrix Metalloproteinase Inhibitors in Cancer Therapy offers basic and clinical investigators alike a richly informative summary of all the latest research on these powerful new drugs, and their high promise as emerging cancer therapeutics.
Editors and Affiliations
-
Corporate V.P., Clinical Affairs, Agouron Pharmaceuticals Inc., San Diego, USA
Neil J. Clendeninn
-
Department of Research Pharmacology, Agouron Pharmaceuticals Inc., San Diego, USA
Krzysztof Appelt
Bibliographic Information
Book Title: Matrix Metalloproteinase Inhibitors in Cancer Therapy
Editors: Neil J. Clendeninn, Krzysztof Appelt
Series Title: Cancer Drug Discovery and Development
DOI: https://doi.org/10.1007/978-1-59259-011-7
Publisher: Humana Totowa, NJ
-
eBook Packages: Springer Book Archive
Copyright Information: Springer Science+Business Media New York 2001
Hardcover ISBN: 978-0-89603-668-0Published: 17 September 2000
Softcover ISBN: 978-1-61737-123-3Published: 29 July 2011
eBook ISBN: 978-1-59259-011-7Published: 17 September 2000
Series ISSN: 2196-9906
Series E-ISSN: 2196-9914
Edition Number: 1
Number of Pages: XIII, 262
Number of Illustrations: 26 b/w illustrations, 3 illustrations in colour
Topics: Oncology